Immunological responses to oxidized LDL

被引:116
作者
Hörkkö, S [1 ]
Binder, CJ [1 ]
Shaw, PX [1 ]
Chang, MK [1 ]
Silverman, G [1 ]
Palinski, W [1 ]
Witztum, JL [1 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
oxidized LDL; atherosclerosis; immunity; free radical; oxidized phospholipids; T cells; immunoglobulins; autoantibodies;
D O I
10.1016/S0891-5849(00)00333-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Considerable evidence now points to an important role for the immune system in experimental models of atherosclerosis. We have reviewed the growing body of evidence that oxidation of LDL generates a wide Variety of neoself determinants that lead to cellular and humoral immune responses. In particular, we have demonstrated that at least some of the oxidation-specific epitopes generated on the oxidized LDL particle, such as oxidized phospholipid epitopes, are also generated on apoptotic cells and are also present on the surface of some bacteria. Many of these same epitopes serve as important ligands mediating the binding and clearance of oxidatively damaged lipoprotein particles and apoptotic cells, and the innate immune response to these epitopes can be seen as a conserted response to effect their removal. In addition, other epitopes of OxLDL also undoubtedly play a role in the immune activation that characterizes the progressive atherosclerotic plaque. It will be of great importance to define the importance of the role of these responses and to understand which are beneficial and which deleterious. Such information could lead one day to novel therapeutic approaches to inhibit atherogenesis that take advantage of the ability to manipulate the immune response. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1771 / 1779
页数:9
相关论文
共 71 条
[21]   Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins [J].
Hörkkö, S ;
Bird, DA ;
Miller, E ;
Itabe, H ;
Leitinger, N ;
Subbanagounder, G ;
Berliner, JA ;
Friedman, P ;
Dennis, EA ;
Curtiss, LK ;
Palinski, W ;
Witztum, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (01) :117-128
[22]   Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies [J].
Iuliano, L ;
Pratico, D ;
Ferro, D ;
Pittoni, V ;
Valesini, G ;
Lawson, J ;
FitzGerald, GA ;
Violi, F .
BLOOD, 1997, 90 (10) :3931-3935
[23]   MONOCLONAL-ANTIBODIES AGAINST LDL FURTHER ENHANCE MACROPHAGE UPTAKE OF LDL AGGREGATES [J].
KHOO, JC ;
MILLER, E ;
PIO, F ;
STEINBERG, D ;
WITZTUM, JL .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (11) :1258-1266
[24]   The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice [J].
Lee, TS ;
Yen, HC ;
Pan, CC ;
Chau, LY .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :734-742
[25]  
Libby P, 1997, CIRCULATION, V96, P4095
[26]  
LIBBY P, 1999, MOL BASIS CARDIOVASC, P349
[27]   TH1 AND TH2 CD4(+) T-CELLS IN THE PATHOGENESIS OF ORGAN-SPECIFIC AUTOIMMUNE-DISEASES [J].
LIBLAU, RS ;
SINGER, SM ;
MCDEVITT, HO .
IMMUNOLOGY TODAY, 1995, 16 (01) :34-38
[28]   Reduction of atherosclerosis in mice by inhibition of CD40 signalling [J].
Mach, F ;
Schönbeck, U ;
Sukhova, GK ;
Atkinson, E ;
Libby, P .
NATURE, 1998, 394 (6689) :200-203
[29]   Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis [J].
Mach, F ;
Schonbeck, U ;
Sukhova, GK ;
Bourcier, T ;
Bonnefoy, JY ;
Pober, JS ;
Libby, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1931-1936
[30]   Protective role of interleukin-10 in atherosclerosis [J].
Mallat, Z ;
Besnard, S ;
Duriez, M ;
Deleuze, V ;
Emmanuel, F ;
Bureau, MF ;
Soubrier, F ;
Esposito, B ;
Duez, H ;
Fievet, C ;
Staels, B ;
Duverger, N ;
Scherman, D ;
Tedgui, A .
CIRCULATION RESEARCH, 1999, 85 (08) :E17-E24